135 related articles for article (PubMed ID: 17881390)
1. Longitudinal magnetic resonance spectroscopic imaging of primary progressive multiple sclerosis patients treated with glatiramer acetate: multicenter study.
Sajja BR; Narayana PA; Wolinsky JS; Ahn CW;
Mult Scler; 2008 Jan; 14(1):73-80. PubMed ID: 17881390
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy.
Laprie A; Pirzkall A; Haas-Kogan DA; Cha S; Banerjee A; Le TP; Lu Y; Nelson S; McKnight TR
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):20-31. PubMed ID: 15850898
[TBL] [Abstract][Full Text] [Related]
3. Biochemical alterations in multiple sclerosis lesions and normal-appearing white matter detected by in vivo 31P and 1H spectroscopic imaging.
Husted CA; Goodin DS; Hugg JW; Maudsley AA; Tsuruda JS; de Bie SH; Fein G; Matson GB; Weiner MW
Ann Neurol; 1994 Aug; 36(2):157-65. PubMed ID: 8053651
[TBL] [Abstract][Full Text] [Related]
4. Glatiramer acetate in primary progressive multiple sclerosis: results of a multinational, multicenter, double-blind, placebo-controlled trial.
Wolinsky JS; Narayana PA; O'Connor P; Coyle PK; Ford C; Johnson K; Miller A; Pardo L; Kadosh S; Ladkani D;
Ann Neurol; 2007 Jan; 61(1):14-24. PubMed ID: 17262850
[TBL] [Abstract][Full Text] [Related]
5. Long-term study of brain 1H-MRS study in multiple sclerosis: effect of glatiramer acetate therapy on axonal metabolic function and feasibility of long-Term H-MRS monitoring in multiple sclerosis.
Khan O; Shen Y; Bao F; Caon C; Tselis A; Latif Z; Zak I
J Neuroimaging; 2008 Jul; 18(3):314-9. PubMed ID: 18304034
[TBL] [Abstract][Full Text] [Related]
6. Proton magnetic resonance spectroscopic findings of cerebral fat embolism induced by triolein emulsion in cats.
Baik SK; Kim YW; Kim HJ; Lee JW; Cho BM; Kim DH; Choi SH; Lee SH; Chang KH
Acta Radiol; 2008 Dec; 49(10):1174-81. PubMed ID: 19031181
[TBL] [Abstract][Full Text] [Related]
7. Glatiramer acetate treatment in PPMS: why males appear to respond favorably.
Wolinsky JS; Shochat T; Weiss S; Ladkani D;
J Neurol Sci; 2009 Nov; 286(1-2):92-8. PubMed ID: 19426995
[TBL] [Abstract][Full Text] [Related]
8. Two-year study of cervical cord volume and myelin water in primary progressive multiple sclerosis.
Laule C; Vavasour IM; Zhao Y; Traboulsee AL; Oger J; Vavasour JD; Mackay AL; Li DK
Mult Scler; 2010 Jun; 16(6):670-7. PubMed ID: 20558500
[TBL] [Abstract][Full Text] [Related]
9. Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis.
Narayana PA; Doyle TJ; Lai D; Wolinsky JS
Ann Neurol; 1998 Jan; 43(1):56-71. PubMed ID: 9450769
[TBL] [Abstract][Full Text] [Related]
10. During 3 years treatment of primary progressive multiple sclerosis with glatiramer acetate, specific antibodies switch from IgG1 to IgG4.
Basile E; Gibbs E; Aziz T; Oger J
J Neuroimmunol; 2006 Aug; 177(1-2):161-6. PubMed ID: 16765453
[TBL] [Abstract][Full Text] [Related]
11. Multicentre proton magnetic resonance spectroscopy imaging of primary progressive multiple sclerosis.
Narayana PA; Wolinsky JS; Rao SB; He R; Mehta M;
Mult Scler; 2004 Jun; 10 Suppl 1():S73-8. PubMed ID: 15218814
[TBL] [Abstract][Full Text] [Related]
12. 3D 1H MRSI of brain tumors at 3.0 Tesla using an eight-channel phased-array head coil.
Osorio JA; Ozturk-Isik E; Xu D; Cha S; Chang S; Berger MS; Vigneron DB; Nelson SJ
J Magn Reson Imaging; 2007 Jul; 26(1):23-30. PubMed ID: 17659562
[TBL] [Abstract][Full Text] [Related]
13. 1H MRSI comparison of white matter and lesions in primary progressive and relapsing-remitting MS.
Suhy J; Rooney WD; Goodkin DE; Capizzano AA; Soher BJ; Maudsley AA; Waubant E; Andersson PB; Weiner MW
Mult Scler; 2000 Jun; 6(3):148-55. PubMed ID: 10871825
[TBL] [Abstract][Full Text] [Related]
14. Proton magnetic resonance spectroscopic imaging in newly diagnosed glioblastoma: predictive value for the site of postradiotherapy relapse in a prospective longitudinal study.
Laprie A; Catalaa I; Cassol E; McKnight TR; Berchery D; Marre D; Bachaud JM; Berry I; Moyal EC
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):773-81. PubMed ID: 18262090
[TBL] [Abstract][Full Text] [Related]
15. Metabolic assessment of the human pons by in vivo proton magnetic resonance spectroscopy.
Guan JT; Xu XH; Geng YQ; Yu XJ; Wu RH
Brain Res; 2008 Aug; 1227():221-5. PubMed ID: 18602897
[TBL] [Abstract][Full Text] [Related]
16. Proton magnetic resonance spectroscopic imaging in the border zone of gliomas: correlation of metabolic and histological changes at low tumor infiltration--initial results.
Stadlbauer A; Nimsky C; Buslei R; Pinker K; Gruber S; Hammen T; Buchfelder M; Ganslandt O
Invest Radiol; 2007 Apr; 42(4):218-23. PubMed ID: 17351427
[TBL] [Abstract][Full Text] [Related]
17. Detection of human immunodeficiency virus induced inflammation and oxidative stress in lenticular nuclei with magnetic resonance spectroscopy despite antiretroviral therapy.
Roc AC; Ances BM; Chawla S; Korczykowski M; Wolf RL; Kolson DL; Detre JA; Poptani H
Arch Neurol; 2007 Sep; 64(9):1249-57. PubMed ID: 17620480
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance spectroscopy features of normal-appearing white matter in patients with acute brucellosis.
Kayabas U; Alkan A; Firat AK; Karakas HM; Bayindir Y; Yetkin F
Eur J Radiol; 2008 Mar; 65(3):417-20. PubMed ID: 17920223
[TBL] [Abstract][Full Text] [Related]
19. Prospective longitudinal proton magnetic resonance spectroscopic imaging in adult traumatic brain injury.
Holshouser BA; Tong KA; Ashwal S; Oyoyo U; Ghamsary M; Saunders D; Shutter L
J Magn Reson Imaging; 2006 Jul; 24(1):33-40. PubMed ID: 16755529
[TBL] [Abstract][Full Text] [Related]
20. [Long-term effects of glatiramer acetate in multiple sclerosis].
Brochet B
Rev Neurol (Paris); 2008 Nov; 164(11):917-26. PubMed ID: 18790510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
